Evidence map›Paper›PMID 23596160›Full record

ArticleThe Journal of nutrition2013

Grape powder supplementation prevents oxidative stress-induced anxiety-like behavior, memory impairment, and high blood pressure in rats.

Farida Allam, An T Dao, Gaurav Chugh, Ritu Bohat, Faizan Jafri, Gaurav Patki, Christopher Mowrey, Mohammad Asghar, Karim A Alkadhi, Samina Salim

Retracted Registry-linked trialOpen access · bronzeAbstract readRetracted Publication
In one paragraph

Article in The Journal of nutrition, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It has been retracted, and should not be counted. It is linked to trial NCT03659695 (Cardioprotective Effects of Freeze Dried Grape Powder Supplementation on Blood Pressure and Plasma Lipids/Lipoproteins), which is not on this map. Cited by 38 papers.

0numbers the graph read from it
0cells of the map it votes in
38citing papers in PubMed
2.6field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03659695 naterminatednot on this mapstarted 2020, after this paper: background citation

Cardioprotective Effects of Freeze Dried Grape Powder Supplementation on Blood Pressure and Plasma Lipids/Lipoproteins: A Pilot Study

TypeinterventionalSponsorUniversity of ArizonaRan2020 to 2024Enrolled16ConditionsCardiovascular Risk FactorArmsGrape Powder, Placebo Powder
3 · Its place in the literature

Who cites it

38 citing papers in PubMed, 66 citations in OpenAlex.

  1. Trial
  2. Salubrious effects of proanthocyanidins on behavioral phenotypes and DNA repair deficiency in the BTBR mouse model of autism.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2024
    Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Farida AllamDepartment of Pharmacological and Pharmaceutical Sciences, University of Houston, Houston, TX, USA.
An T Dao
Gaurav Chugh
Ritu Bohat
Faizan Jafri
Gaurav Patki
Christopher Mowrey
Mohammad Asghar
Karim A Alkadhi
Samina Salim
University of Houston · US

Funding

Renal Dopamine and Angiotensin II Receptor Function in Age-Related HypertensionR01AG039836 · NIA · UNIVERSITY OF HOUSTON · PI ASGHAR, MOHAMMAD · 2011 to 2015
$1.5M
Oxidative Stress: A Recipe for Anxiety and Cognitive ImpairmentR15MH093918 · NIMH · UNIVERSITY OF HOUSTON · PI SALIM, SAMINA · 2012 to 2015
$895k
NIA NIH HHS R01 AG039836NIMH NIH HHS R15 MH093918PHS HHS R15 G103327
6 · The paper itself

Abstract

We examined whether or not grape powder treatment ameliorates oxidative stress-induced anxiety-like behavior, memory impairment, and hypertension in rats. Oxidative stress in Sprague-Dawley rats was produced by using L-buthionine-(S,R)-sulfoximine (BSO). Four groups of rats were used: 1) control (C; injected with vehicle and provided with tap water), 2) grape powder-treated (GP; injected with vehicle and provided for 3 wk with 15 g/L grape powder dissolved in tap water), 3) BSO-treated [injected with BSO (300 mg/kg body weight), i.p. for 7 d and provided with tap water], and 4) BSO plus grape powder-treated (GP+BSO; injected with BSO and provided with grape powder-treated tap water). Anxiety-like behavior was significantly greater in BSO rats compared with C or GP rats (P < 0.05). Grape powder attenuated BSO-induced anxiety-like behavior in GP+BSO rats. BSO rats made significantly more errors in both short- and long-term memory tests compared with C or GP rats (P < 0.05), which was prevented in GP+BSO rats. Systolic and diastolic blood pressure was significantly greater in BSO rats compared with C or GP rats (P < 0.05), whereas grape powder prevented high blood pressure in GP+BSO rats. Furthermore, brain extracellular signal-regulated kinase-1/2 (ERK-1/2) was activated (P < 0.05), whereas levels of glyoxalase-1 (GLO-1), glutathione reductase-1 (GSR-1), calcium/calmodulin-dependent protein kinase type IV (CAMK-IV), cAMP response element-binding protein (CREB), and brain-derived neurotrophic factor (BDNF) were significantly less (P < 0.05) in BSO but not in GP+BSO rats compared with C or GP rats. We suggest that by regulating brain ERK-1/2, GLO-1, GSR-1, CAMK-IV, CREB, and BDNF levels, grape powder prevents oxidative stress-induced anxiety, memory impairment, and hypertension in rats.

Indexed as

AnimalsAnxietyBehavior, AnimalBrain ChemistryBrain-Derived Neurotrophic FactorButhionine SulfoximineCalcium-Calmodulin-Dependent Protein Kinase Type 4Cyclic AMP Response Element-Binding ProteinDietary SupplementsDisease Models, AnimalExtracellular Signal-Regulated MAP KinasesFood, PreservedFreeze DryingFruitGlutathione ReductaseHypertensionBrain-Derived Neurotrophic FactorButhionine SulfoximineCalcium-Calmodulin-Dependent Protein Kinase Type 4Cyclic AMP Response Element-Binding ProteinExtracellular Signal-Regulated MAP KinasesGlutathione ReductaseLactoylglutathione LyasePolyphenols

Identifiers

PMID23596160
PMCPMC3652881
OpenAlexW2113110491

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.